1. Introduction {#sec0005}
===============

The emergence and spread of resistance against known antimicrobials has renewed interest in the discovery of microbial natural products with antimicrobial properties. Recent studies have revealed that microbes found in the Red Sea can produce a variety of antimicrobial compounds \[[@bib0005], [@bib0010], [@bib0015], [@bib0020]\]. The sequencing of microbial genomes has revealed the immense genetic potential of microbes to synthesize bioactive secondary metabolites \[[@bib0025]\]; however, the vast majority of secondary metabolites has remained unidentified \[[@bib0030]\].

In a recent study, we isolated bacteria, from the Red Sea sediments, in the vicinity of seagrass, and tested their ability to degrade Acyl Homoserine Lactone (AHL) molecules \[[@bib0035]\]. While doing the initial screening, we observed that the culture supernatant of one isolate could kill the biosensor strain *Chromobacter violaceum* CV026 used in the assay ([Fig. 1](#fig0005){ref-type="fig"}). We hypothesized that this isolate produced secondary metabolites with antimicrobial properties. Therefore, we sequenced the genome of this isolate in order to investigate the genetic potential of this bacterium to synthesize such metabolites. The 16S-rRNA gene sequence showed a high homology (99% identity) to the *Z. ganghwensis* strain JC2044, which was isolated from sediments samples from Getbol in Korea \[[@bib0040]\]. Similarly, to other *Zooshikella* isolates, this isolate also produced a red pigment that gave a red color to the colony. The red pigment was identified as Prodigiosin, which has shown anticancer and antimicrobial properties \[[@bib0045],[@bib0050]\].Fig. 1*Z. ganghwensis* strain VG4 exhibiting antimicrobial activity. A clear halo (diameter = 11 ± 1 mm including well) around VG4, shown by the arrow, showed killing of *C. violaceum*. However, *C. violaceum* was able to grow at some distance from the well, as indicated by the purple color. Other bacterial isolates (VG5, VG9, VG10) and a negative control (PBS + C6-AHLs) did not inhibit the growth of *C. violaceum*. This is a representative figure of two independent replicates.Fig. 1

2. Strain isolation and QQ assay {#sec0010}
================================

Red Sea sediments were collected at a depth of 1--2 m, from the coastal area 12 km North of Thuwal (22.389778, 39.135556), Saudi Arabia. Sediments were acquired using a 30-cm-long acrylic cylindrical tube. Sampled sediments were stored at 30 °C, and bacteria were isolated at the earliest to avoid any negative effect due to storage. For bacterial isolation, approximately 1 *g* of sea sediments were suspended in 1 mL of 0.2-μm filtered autoclaved seawater, and vortexed. This mixture was left to stand for 1--2 min to allow the bigger particles to settle down. The supernatant was then serially diluted (10-fold), and plated on Marine Agar (MA) (HIMEDIA, India). The plates were incubated at 30 °C, for 1 week. Selected bacterial colonies were further sub-cultured onto fresh agar plates. Single colonies were subsequently streaked twice to obtain pure cultures. Quorum-quenching assay was conducted as described previously \[[@bib0035]\]. Briefly, the isolates were grown in 0.5 mL of Marine broth and incubated at 30 °C with shaking. C6-AHLs were added to this bacterial culture to reach a final concentration of 10 μM and further incubated for 24 h at 30 °C with shaking. The bacterial cultures were centrifuged to pellet the cells, and the remaining C6-AHLs in the culture supernatant were detected by adding it to the wells of the LB agar plate overlaid with *C. violaceum*. The plate was incubated further for 24 h at 37 °C A purple halo indicated an absence of QQ activity (i.e no degradation of C6-AHLs), whereas no halo indicated a degradation of C6-AHLs.

3. Genome sequencing and analysis {#sec0015}
=================================

For the genome sequencing, the genomic DNA was extracted, using a DNA blood and tissue kit from Qiagen. The library for the whole genome sequencing was prepared by following the Pacific Biosciences (PacBio) 20-kb Template preparation protocol, also using the BluePippin Size Selection System protocol, and subsequently sequenced on PacBio RS platform. The PacBio chemistry resulted in 49,247 reads and 7.9 Gb of data.

The PacBio sequence reads were assembled, using a CANU WGS assembler \[[@bib0055]\] version 1.4 with default parameters. Assembly of the whole genome yielded 12 contigs with N50 of 5.9Mb and a total genome size of 6.6 Mbp. GC content of the genome was 41.09%. Functional annotation of this bacterium was performed using the Automatic Annotation of Microbial Genomes (AAMG) pipeline \[[@bib0060]\]. Briefly, this annotation pipeline first validated the sequence quality using prinseq \[[@bib0065]\]. The RNA prediction was then carried out using RNAmmer \[[@bib0070]\], tRNAscan-SE \[[@bib0075]\] and Infernal \[[@bib0080]\]. Open Reading Frames (ORFs were predicted using FragGenScan \[[@bib0085]\]. RNA predictions were compared with the latest NCBI's 16S-rRNA database and EBI's Rfam \[[@bib0090]\] database, using nucleotide BLAST. ORFs were compared to the latest version of UniProt/Trembl \[[@bib0095]\] and KEGG \[[@bib0100]\] databases. Domains and Gene Ontology assignments were performed using high- throughput Interproscan analysis \[[@bib0105]\]. Out of a total of 7634 (ORF + RNA genes) genes that were identified, 74% were annotated ([Table 1](#tbl0005){ref-type="table"}). NCBI annotations of the genome are available online at URL: https://bit.ly/2w6lelITable 1Counts of genomic features annotated through different sources.Table 1Genome FeaturesCountsORFs7502rRNA12tRNA60rfamRNA60Uniprot5482KEGG3742COG2906InterPro4076GO2603Total Annotated Genes5639Total Unassigned Genes1995

(http://www.cbrc.kaust.edu.sa/aamg/1487944605297_VG4_30.0_intikhab/)

4. Prediction of NRP and PK synthases {#sec0020}
=====================================

It has been suggested that large enzyme complexes, such as polyketide synthases and nonribosomal peptide synthetases, synthesize the majority of the bioactive natural products \[[@bib0110]\]. Different bioinformatic approaches have been developed for identifying such enzymes in the genomes, and for predicting the structures of polyketides (PK) and nonribosomal peptides (NRP) produced by these enzyme \[[@bib0115],[@bib0120]\]. These bioinformatic tools search for protein domains such as thiolation, condensation, acyltransferase, and adenylation domains that are involved in the biosynthesis of natural products.

For the prediction of PK synthases and NRP synthetases, we used an open-source web application called PRISM 3 (PRediction Informatics for Secondary Metabolomes). This computational resource is a valuable tool for the prediction of gene clusters involved in the biosynthesis of bioactive secondary metabolites such as type I and type II PK and NRP and their structures \[[@bib0125]\].

An analysis of the *Z. ganghwensis* genome sequence, using PRISM, resulted in the identification of 5 gene clusters that could potentially synthesize NRP and PK ([Table 2](#tbl0010){ref-type="table"}). Two of the gene clusters were capable of synthesizing both NRP and PK. It is not clear if such gene clusters can produce both PK and NRP secondary metabolites, or a molecule that is a hybrid of both. Two gene clusters synthesized only NRP, and one gene cluster synthesized only PK ([Table 2](#tbl0010){ref-type="table"}). Cluster 1 consists of four open reading frames (ORF), two of which encode the antimicrobial resistance genes, a third one, VG4_000000308, that carry five domains involved in the synthesis of NRP, and a fourth ORF, VG4_000000309, that encodes a protein containing 14 domains, involved in the biosynthesis of both NRP and PK. We found that the modular structure of these ORFs was typical to that found in NRP and PK synthases \[[@bib0030]\]. The predicted structure of the secondary metabolite produced by this cluster is presented in [Fig. 2](#fig0010){ref-type="fig"}A. Predicted cluster 2 contains only one ORF, and its protein product is predicted to consist of 7 domains, involved in the production of NRP. The predicted structure of NRPs produced by this ORF is shown in [Fig. 2](#fig0010){ref-type="fig"}B. Cluster 3 consists of three ORFs, and can only synthesize NRP. The predicted structure of NRPs synthesized by this cluster is shown in [Fig. 2](#fig0010){ref-type="fig"}C. Cluster 4 consists of four ORFs each with one domain. This cluster is capable of synthesizing only PKs ([Table 2](#tbl0010){ref-type="table"}). PRISM was unable to predict the structure of PKs synthesized by this cluster. Lastly, we found that cluster 5 contained three ORFs and that the protein product of VG4_000004243 contained 9 domains, usually involved in the biosynthesis of NRP and PK. The protein product of VG4_000004245 is predicted to contain 6 domains involved in the synthesis of NRP only ([Fig. 2](#fig0010){ref-type="fig"}D). We note that AAMG annotations for PRISM detected genes are in good agreement ([Table 2](#tbl0010){ref-type="table"}).Table 2ORFs predicted by PRISM, their KEGG (Kyoto Encyclopedia of genes and Genomes) orthologs and functions. ORFs predicted by PRISM were BLASTed against the protein sequences predicted for VG4 genome to obtain the ORF IDs that correspond to our annotations (link given above).Table 2ClustersMetabolitesORF IDsKEGG OrthologAAMG FunctionCluster 1PK/NRPVG4_000000305K07552, bcrMulti drug resistance proteinVG4_000000308K16093, bacABacitracin synthaseVG4_000000309K15662, mycBLipopeptide synthetase BVG4_000000311K06158, ABCF3ATP-binding cassetteCluster 2NRPVG4_000002985K04780, dhbFNRP synthetaseCluster 3NRPVG4_000003153K02363, entE2,3-dihydroxybenzoate-AMP ligaseVG4_000003154IsochorismataseVG4_000003155K02364, entFEnterobactin synthetase component FVG4_000003161K02362, entDEnterobactin synthetase component DCluster 4PKVG4_000003613K02619, pabC4-amino-4-deoxychorismate lyaseVG4_000003614K09458, fabF3-oxoacyl-\[acyl-carrier-protein\] synthase IIVG4_000003615K02078, acpPAcyl carrier proteinVG4_000003617K00645, fabDS-malonyltransferaseCluster 5PK/NRPVG4_000004243K16129, mcyEMicrocystin synthetaseVG4_000004244K01953, asnBAsparagine synthaseVG4_000004245K15667, ppsDLipopeptide synthetase DFig. 2Structure of secondary metabolites predicted by PRISM. (A) Structure of NRP/PK as predicted for Cluster 1. (B), (C) Structure of NRP predicted for cluster 2 and 3 respectively and (D) structure of NRP/PK, as predicted for cluster 5. PRISM was unable to predict structure for PK synthesized by cluster 4. These metabolites were named using ChemDraw as (A) 4-(2-(1-(2-(aminomethyl)-4,5-dihydrothiazole-4-carboxamido)-2-hydroxyethyl)-4,5-dihydrothiazole-4-carboxamido)-3-oxobutanoic acid, (B) 2-(2-(3-hydroxydecanamido)-3-phenylpropanamido) hexanoic acid, (C) (2,3-dihydroxybenzoyl)serine, (D) 3-(3-carboxy-2-(3-oxohexadecanamido)propanamido)-4-((1-carboxy-2-phenylethyl)amino)-2-methyl-4-oxobutanoic acid.Fig. 2

5. Conclusions {#sec0025}
==============

In this study, a phenotypic and genomic analysis showed that *Z. ganghwensis* strain VG4 produced secondary metabolites with potential antimicrobial activity. This antimicrobial activity could be the result of Prodigiosin or other secondary metabolites, such as PK and NRP, that are potentially produced by this bacterium. In future studies, our goals will be to confirm the production of these metabolites and to investigate their bioactivity.

Data deposition {#sec0030}
===============

The BioProject ID for this genome submission is PRJNA383317.

This Whole Genome Shotgun project was deposited at DDBJ/ENA/GenBank, under the accession number [NDXW00000000](ncbi-wgs:NDXW00000000){#intr0005}. The version described in this paper is version [NDXW01000000](ncbi-wgs:NDXW01000000){#intr0010}.
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